Apothecary Capital

Apothecary Capital LLC is a US-based financial advisory and venture capital firm that focuses on investing in later-stage companies, typically participating in Series C and other unspecified rounds. The firm primarily targets the healthcare and pharmaceutical sectors, with a particular interest in innovative drug development and biotechnology.

Notable portfolio companies include Cogentus Pharmaceuticals, which has raised $62.5 million, and FibroGen, which has raised $100 million. Apothecary Capital's investment philosophy centers around supporting high-potential companies with substantial growth prospects. The firm is known for its strategic guidance and financial expertise, helping portfolio companies navigate complex regulatory environments and scale their operations effectively.